力诺药包涨2.01%，成交额4957.84万元，主力资金净流入428.83万元

Core Viewpoint - Linuo Pharmaceutical Packaging Co., Ltd. has experienced fluctuations in stock performance, with a year-to-date increase of 19.08% and a recent decline over the past 60 days of 17.88% [2] Company Overview - Linuo Pharmaceutical Packaging, established on March 1, 2002, and listed on November 11, 2021, is located in Shandong Province, China [2] - The company specializes in the research, production, and sales of specialty glass, focusing on borosilicate glass development and application [2] - Revenue composition includes heat-resistant glass (57.02%), pharmaceutical glass (40.74%), and other material sales (2.24%) [2] - The company operates within the pharmaceutical and biological industry, specifically in medical devices and consumables [2] Financial Performance - For the first half of 2025, Linuo Pharmaceutical reported revenue of 499 million yuan, a year-on-year decrease of 11.07% [2] - The net profit attributable to the parent company was approximately 40.97 million yuan, reflecting a year-on-year decline of 20.12% [2] Shareholder Information - As of June 30, 2025, the number of shareholders increased by 17.08% to 11,100 [2] - The average number of circulating shares per shareholder decreased by 12.16% to 21,522 shares [2] - Cumulative cash dividends since the company's A-share listing amount to 139 million yuan, with 92.18 million yuan distributed over the past three years [3] Institutional Holdings - As of June 30, 2025, notable institutional shareholders include Guotai Junan Value Advantage Flexible Allocation Mixed Fund, which holds 5.90 million shares, a decrease of 1.55 million shares from the previous period [3] - Guotai Junan Innovation Growth Mixed Fund holds 2.87 million shares, down by 530,000 shares [3] - Guotai Junan Pharmaceutical Health Stock A is a new shareholder with 2.79 million shares [3]